NT-I7 in Combination With Nivolumab in Advanced Gastric, Gastro-Esophageal Junction or Esophageal Adenocarcinoma
Clinical trial NCT04594811 · TERMINATED
Trial details
- NCT number
- NCT04594811
- Sponsor
- NeoImmuneTech
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-21
- Primary completion
- 2023-05-26
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.